These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 953487)

  • 1. Proceedings: The effect of Corynebacterium parvum on a subcutaneous tumour.
    Jones PD; Sadler TE; Castro JE
    Br J Surg; 1976 Aug; 63(8):659-60. PubMed ID: 953487
    [No Abstract]   [Full Text] [Related]  

  • 2. Organ distribution of technetium-99m-labeled corynebacterium parvum in normal and tumor-bearing mice.
    Barth RF; Singla O
    Cancer Res; 1978 Jan; 38(1):32-4. PubMed ID: 618580
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Combined surgery and Corynebacterium parvum for treatment of metastasizing tumour in mice.
    Castro JE; Sadler TE
    Br J Surg; 1975 Feb; 62(2):156. PubMed ID: 1115892
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Therapy of methyl cholanthrene induced CBA mouse tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Aug; 32(2):241. PubMed ID: 1212356
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
    [No Abstract]   [Full Text] [Related]  

  • 7. A bladder tumor model response to immunotherapy.
    deKernion JB; Ramming KP; Fraser K
    Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histopathological aspects and macrophage reactivity in rats with Guerin's T8 viral tumor after treatment with Corynebacterium parvum].
    Caruso R; Bonina L; Chimicata S; Iannello D; Inferrera C; Mastroeni P
    Arch De Vecchi Anat Patol; 1979 Mar; 63(3):491-9. PubMed ID: 262125
    [No Abstract]   [Full Text] [Related]  

  • 10. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
    Suit HD; Sedlacek R; Silobrcic V
    Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: The action of subcutaneous and intravenous Corynebacterium parvum on the "lymphocyte trap".
    Hamilton DN; Brady E
    Br J Surg; 1975 Feb; 62(2):156. PubMed ID: 1115893
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Corynebacterium parvum on tumour metastases in mice.
    Castro JE
    Br J Surg; 1977 Oct; 64(10):721-4. PubMed ID: 922293
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Local Corynebacterium parvum therapy in early breast cancer.
    Ackroyd NW; Boak JL
    Br J Surg; 1976 Aug; 63(8):659. PubMed ID: 953485
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corynebacteria--stimulators of antitumor resistance].
    Zatula DG; Zaval'niuk AK; Tofan AV
    Eksp Onkol; 1984; 6(6):12-8. PubMed ID: 6396064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of success in classical immunotherapy to the relative immunorejective strength of the tumor.
    Reif AE
    J Natl Cancer Inst; 1986 Oct; 77(4):899-908. PubMed ID: 3020300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by Corynebacterium parvum against tumour cells injected intravenously.
    Milas L; Mujagić H
    Rev Eur Etud Clin Biol; 1972 May; 17(5):498-500. PubMed ID: 4648182
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
    Scott MT
    J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
    Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
    Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.